J J Bian - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Cell Death & Disease|December 19, 2014

Mitochondrial inhibitor sensitizes non-small-cell lung carcinoma cells to TRAIL-induced apoptosis by reactive oxygen species and Bcl-X(L)/p53-mediated amplification mechanismsY L Shi, S Feng, W Chen, et al.

Scientific Reports|June 17, 2018

Ductile bulk metallic glass by controlling structural heterogeneitiesS Scudino, J J Bian, H Shakur Shahabi, et al.

Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|October 15, 2018

[Expression of Fermintin family homologous protein 2 in non-small cell lung cancer and its clinical significance]W H Guo, J J Bian, G F Tian, et al.

Anaesthesia|December 10, 2009

NFKB1-94ins/del polymorphism is not associated with lung injury after cardiopulmonary bypassJ F Wang, J J Bian, X J Wan, et al.

Breast Cancer Research and Treatment|June 4, 2021

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) studyM L Lopresti, J J Bian, B J Sakr, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Cell Death & Disease|December 19, 2014

Mitochondrial inhibitor sensitizes non-small-cell lung carcinoma cells to TRAIL-induced apoptosis by reactive oxygen species and Bcl-X(L)/p53-mediated amplification mechanismsY L Shi, S Feng, W Chen, et al.

Scientific Reports|June 17, 2018

Ductile bulk metallic glass by controlling structural heterogeneitiesS Scudino, J J Bian, H Shakur Shahabi, et al.

Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|October 15, 2018

[Expression of Fermintin family homologous protein 2 in non-small cell lung cancer and its clinical significance]W H Guo, J J Bian, G F Tian, et al.

Anaesthesia|December 10, 2009

NFKB1-94ins/del polymorphism is not associated with lung injury after cardiopulmonary bypassJ F Wang, J J Bian, X J Wan, et al.

Breast Cancer Research and Treatment|June 4, 2021

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) studyM L Lopresti, J J Bian, B J Sakr, et al.

Pageof 1